Alpha and Omega Semiconductor Reports Financial Results for Fiscal Fourth Quarter and Fiscal Year Ended June 30, 2025
The results for the fiscal fourth quarter ended
GAAP Financial Comparison |
||||||||||||
Quarterly |
||||||||||||
(in millions, except percentage and per share data) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
|
||||||
Revenue |
|
$ |
176.5 |
|
|
$ |
164.6 |
|
|
$ |
161.3 |
|
Gross Margin |
|
|
23.4 |
% |
|
|
21.4 |
% |
|
|
25.7 |
% |
Operating Loss |
|
$ |
(11.6 |
) |
|
$ |
(10.7 |
) |
|
$ |
(1.5 |
) |
Net Loss |
|
$ |
(77.1 |
) |
|
$ |
(10.8 |
) |
|
$ |
(2.7 |
) |
Net Loss Per Share - Diluted |
|
$ |
(2.58 |
) |
|
$ |
(0.37 |
) |
|
$ |
(0.09 |
) |
Non-GAAP Financial Comparison |
||||||||||||
Quarterly |
||||||||||||
(in millions, except percentage and per share data) |
||||||||||||
(unaudited) |
||||||||||||
|
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
|
||||||
Revenue |
|
$ |
176.5 |
|
|
$ |
164.6 |
|
|
$ |
161.3 |
|
Non-GAAP Gross Margin |
|
|
24.4 |
% |
|
|
22.5 |
% |
|
|
26.4 |
% |
Non-GAAP Operating Income (Loss) |
|
$ |
2.3 |
|
|
$ |
(2.7 |
) |
|
$ |
3.2 |
|
Non-GAAP Net Income (Loss) |
|
$ |
0.7 |
|
|
$ |
(2.9 |
) |
|
$ |
2.6 |
|
Non-GAAP Net Income (Loss) Per Share - Diluted |
|
$ |
0.02 |
|
|
$ |
(0.10 |
) |
|
$ |
0.09 |
|
The non-GAAP financial measures in the schedule above and under the section "Financial Results for Fiscal Q4 Ended
The results for the fiscal year ended
GAAP Financial Comparison |
||||||||
Annually |
||||||||
(in millions, except percentage and per share data) |
||||||||
(unaudited) |
||||||||
|
|
Year Ended |
||||||
|
|
2025 |
|
2024 |
||||
Revenue |
|
$ |
696.2 |
|
|
$ |
657.3 |
|
Gross Margin |
|
|
23.1 |
% |
|
|
26.2 |
% |
Operating Loss |
|
$ |
(28.4 |
) |
|
$ |
(3.8 |
) |
Net Loss |
|
$ |
(97.0 |
) |
|
$ |
(11.1 |
) |
Net Loss Per Share - Diluted |
|
$ |
(3.30 |
) |
|
$ |
(0.39 |
) |
Non-GAAP Financial Comparison |
||||||||
Annually |
||||||||
(in millions, except percentage and per share data) |
||||||||
(unaudited) |
||||||||
|
|
Year Ended |
||||||
|
|
2025 |
|
2024 |
||||
Revenue |
|
$ |
696.2 |
|
|
$ |
657.3 |
|
Non-GAAP Gross Margin |
|
|
24.2 |
% |
|
|
27.2 |
% |
Non-GAAP Operating Income |
|
$ |
10.4 |
|
|
$ |
21.7 |
|
Non-GAAP Net Income |
|
$ |
7.0 |
|
|
$ |
18.5 |
|
Non-GAAP Net Income Per Share - Diluted |
|
$ |
0.22 |
|
|
$ |
0.62 |
|
The non-GAAP financial measures in the schedule above exclude the effect of share-based compensation expenses, amortization of purchased intangible,
settlement and
legal costs related to government investigation, equity method investment loss from equity investee, and income tax effect of non-GAAP adjustments for fiscal years ended
Financial Results for Fiscal Q4 Ended
-
Revenue was
$176.5 million , an increase of 9.4% from the same quarter last year and an increase of 7.2% quarter-over-quarter. - GAAP gross margin was 23.4%, down from 25.7% year-over-year and up from 21.4% in the prior quarter.
- Non-GAAP gross margin was 24.4%, down from 26.4% from the same quarter last year and up from 22.5% in the prior quarter.
-
GAAP operating expenses were
$52.9 million , up from$45.8 million in the prior quarter and up from$42.9 million from the same quarter last year. -
Non-GAAP operating expenses were
$40.9 million , up from$39.7 million from last quarter and up from$39.3 million from the same quarter last year. -
GAAP operating loss was
$11.6 million , up from$1.5 million from the same quarter last year and up from$10.7 million in the prior quarter. -
Non-GAAP operating income was
$2.3 million as compared to$3.2 million for the same quarter last year and an operating loss of$2.7 million from last quarter. -
GAAP net loss per share was
$2.58 , compared to$0.37 for the prior quarter and$0.09 per share for the same quarter last year. -
Non-GAAP earnings per share was
$0.02 , compared to$0.10 net loss per share for the prior quarter and$0.09 net earnings per share for the same quarter last year. -
Consolidated cash flow used in operating activities was
$2.8 million , as compared to$7.4 million of consolidated cash flow provided by operating activities in prior quarter. -
The Company closed the quarter with
$153.1 million of cash and cash equivalents.
AOS Chief Executive Officer
Business Outlook for Fiscal Q1 Ending
The following statements are based on management's current expectations. These statements are forward-looking, and actual results may differ materially. AOS undertakes no obligation to update these statements.
-
Revenue is expected to be
$183 million plus or minus$10 million . - GAAP gross margin is expected to be 23.8% plus or minus 1%. Non-GAAP gross margin is expected to be 24.4% plus or minus 1%.
-
GAAP operating expenses are expected to be in the range of
$47.5 million , plus or minus$1 million . Non-GAAP operating expenses are expected to be in the range of$41.0 million plus or minus$1 million . -
Interest income is expected to be
$0.5 million higher than interest expense, and -
Tax expense is expected to be in the range of
$1.0 million to$1.3 million .
Conference Call and Webcast
AOS plans to hold an investor teleconference and live webcast to discuss the financial results for the fiscal fourth quarter and the fiscal year ended
Forward Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, market trends in the semiconductor industry and growth in calendar year 2025, our ability to outperform market, seasonality of our business, our ability to sustain growth and expand our end markets, macro and geopolitical uncertainties, our projected amount of revenue, gross margin, operating income (loss), income tax expenses, net income (loss), and share-based compensation expenses, non-GAAP gross margin, non-GAAP operating expenses, income tax expenses, our ability to grow our sales, market share and BOM content, and other information under the section entitled “Business Outlook for Fiscal Q1 Ending
Use of Non-GAAP Financial Measures
To supplement our unaudited consolidated financial statements presented on a basis consistent with
About
The following unaudited consolidated financial statements are prepared in accordance with
|
|||||||||||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||||||||||
(in thousands, except percentages and per share amounts) |
|||||||||||||||||||
(unaudited) |
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Three Months Ended |
|
Fiscal Year Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Revenue |
$ |
176,484 |
|
|
$ |
164,635 |
|
|
$ |
161,296 |
|
|
$ |
696,162 |
|
|
$ |
657,274 |
|
Cost of goods sold |
|
135,194 |
|
|
|
129,458 |
|
|
|
119,859 |
|
|
|
535,158 |
|
|
|
485,356 |
|
Gross profit |
|
41,290 |
|
|
|
35,177 |
|
|
|
41,437 |
|
|
|
161,004 |
|
|
|
171,918 |
|
Gross margin |
|
23.4 |
% |
|
|
21.4 |
% |
|
|
25.7 |
% |
|
|
23.1 |
% |
|
|
26.2 |
% |
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||||||||
Research and development |
|
24,421 |
|
|
|
23,398 |
|
|
|
21,813 |
|
|
|
94,265 |
|
|
|
89,940 |
|
Selling, general and administrative |
|
28,487 |
|
|
|
22,437 |
|
|
|
21,123 |
|
|
|
95,175 |
|
|
|
85,734 |
|
Total operating expenses |
|
52,908 |
|
|
|
45,835 |
|
|
|
42,936 |
|
|
|
189,440 |
|
|
|
175,674 |
|
Operating loss |
|
(11,618 |
) |
|
|
(10,658 |
) |
|
|
(1,499 |
) |
|
|
(28,436 |
) |
|
|
(3,756 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||||
Other income (loss), net |
|
(952 |
) |
|
|
(65 |
) |
|
|
65 |
|
|
|
(1,004 |
) |
|
|
(73 |
) |
Interest income |
|
956 |
|
|
|
927 |
|
|
|
1,295 |
|
|
|
4,283 |
|
|
|
5,168 |
|
Interest expenses |
|
(530 |
) |
|
|
(596 |
) |
|
|
(883 |
) |
|
|
(2,639 |
) |
|
|
(3,982 |
) |
Gain on change of equity interest in equity method investment |
|
— |
|
|
|
505 |
|
|
|
— |
|
|
|
505 |
|
|
|
— |
|
Impairment of equity method investment |
|
(76,784 |
) |
|
|
— |
|
|
|
— |
|
|
|
(76,784 |
) |
|
|
— |
|
Net loss before income tax expense (benefit) and income (loss) from equity method investment |
|
(88,928 |
) |
|
|
(9,887 |
) |
|
|
(1,022 |
) |
|
|
(104,075 |
) |
|
|
(2,643 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||||
Income tax expense (benefit) |
|
(11,567 |
) |
|
|
660 |
|
|
|
1,006 |
|
|
|
(8,625 |
) |
|
|
3,649 |
|
Net loss before income (loss) from equity method investment |
|
(77,361 |
) |
|
|
(10,547 |
) |
|
|
(2,028 |
) |
|
|
(95,450 |
) |
|
|
(6,292 |
) |
Equity method investment income (loss) from equity investee |
|
302 |
|
|
|
(260 |
) |
|
|
(704 |
) |
|
|
(1,526 |
) |
|
|
(4,789 |
) |
Net loss |
$ |
(77,059 |
) |
|
$ |
(10,807 |
) |
|
$ |
(2,732 |
) |
|
$ |
(96,976 |
) |
|
$ |
(11,081 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||||
Net loss per common share |
|
|
|
|
|
|
|
|
|
||||||||||
Basic |
$ |
(2.58 |
) |
|
$ |
(0.37 |
) |
|
$ |
(0.09 |
) |
|
$ |
(3.30 |
) |
|
$ |
(0.39 |
) |
Diluted |
$ |
(2.58 |
) |
|
$ |
(0.37 |
) |
|
$ |
(0.09 |
) |
|
$ |
(3.30 |
) |
|
$ |
(0.39 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||||
Weighted average number of common shares used to compute net loss per share: |
|
|
|
|
|
|
|
|
|
||||||||||
Basic |
|
29,924 |
|
|
|
29,530 |
|
|
|
28,879 |
|
|
|
29,405 |
|
|
|
28,236 |
|
Diluted |
|
29,924 |
|
|
|
29,530 |
|
|
|
28,879 |
|
|
|
29,405 |
|
|
|
28,236 |
|
|
|||||||
Condensed Consolidated Balance Sheets |
|||||||
(in thousands, except par value per share) |
|||||||
(unaudited) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
153,079 |
|
|
$ |
175,127 |
|
Restricted cash |
|
419 |
|
|
|
413 |
|
Accounts receivable, net |
|
34,772 |
|
|
|
12,546 |
|
Inventories |
|
189,677 |
|
|
|
195,750 |
|
Other current assets |
|
16,604 |
|
|
|
14,165 |
|
Total current assets |
|
394,551 |
|
|
|
398,001 |
|
Property, plant and equipment, net |
|
314,097 |
|
|
|
336,619 |
|
Operating lease right-of-use assets, net |
|
21,288 |
|
|
|
25,050 |
|
Intangible assets, net |
|
269 |
|
|
|
3,516 |
|
Equity method investment |
|
279,122 |
|
|
|
356,039 |
|
Deferred income tax assets |
|
599 |
|
|
|
549 |
|
Other long-term assets |
|
22,766 |
|
|
|
25,239 |
|
Total assets |
$ |
1,032,692 |
|
|
$ |
1,145,013 |
|
LIABILITIES AND EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
60,044 |
|
|
$ |
45,084 |
|
Accrued liabilities |
|
57,416 |
|
|
|
72,371 |
|
Payable related to equity investee, net |
|
15,809 |
|
|
|
13,682 |
|
Income taxes payable |
|
1,790 |
|
|
|
2,798 |
|
Short-term debt |
|
11,852 |
|
|
|
11,635 |
|
Deferred revenue |
|
— |
|
|
|
2,591 |
|
Finance lease liabilities |
|
1,007 |
|
|
|
935 |
|
Operating lease liabilities |
|
4,978 |
|
|
|
5,137 |
|
Total current liabilities |
|
152,896 |
|
|
|
154,233 |
|
Long-term debt |
|
14,872 |
|
|
|
26,724 |
|
Income taxes payable - long-term |
|
4,201 |
|
|
|
3,591 |
|
Deferred income tax liabilities |
|
13,192 |
|
|
|
26,416 |
|
Finance lease liabilities - long-term |
|
1,274 |
|
|
|
2,282 |
|
Operating lease liabilities - long-term |
|
16,925 |
|
|
|
20,499 |
|
Other long-term liabilities |
|
7,000 |
|
|
|
19,661 |
|
Total liabilities |
|
210,360 |
|
|
|
253,406 |
|
Commitments and contingencies |
|
|
|
||||
Shareholders' Equity: |
|
|
|
||||
Preferred shares, par value |
|
|
|
||||
Authorized: 10,000 shares; issued and outstanding: none at |
|
— |
|
|
|
— |
|
Common shares, par value |
|
|
|
||||
Authorized: 100,000 shares; issued and outstanding: 37,127 shares and 30,009 shares, respectively at |
|
74 |
|
|
|
72 |
|
|
|
(79,058 |
) |
|
|
(79,213 |
) |
Additional paid-in capital |
|
379,779 |
|
|
|
353,109 |
|
Accumulated other comprehensive loss |
|
(12,390 |
) |
|
|
(13,419 |
) |
Retained earnings |
|
533,927 |
|
|
|
631,058 |
|
Total shareholders' equity |
|
822,332 |
|
|
|
891,607 |
|
Total liabilities and shareholders' equity |
$ |
1,032,692 |
|
|
$ |
1,145,013 |
|
|
|||||||
Selected Cash Flow Information |
|||||||
(in thousands) |
|||||||
(unaudited) |
|||||||
|
|
|
|
||||
|
Fiscal Year Ended |
||||||
|
2025 |
|
2024 |
||||
Net cash provided by operating activities |
$ |
29,668 |
|
|
$ |
25,710 |
|
Net cash used in investing activities |
|
(36,441 |
) |
|
|
(35,744 |
) |
Net cash used in financing activities |
|
(15,496 |
) |
|
|
(9,903 |
) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
227 |
|
|
|
(126 |
) |
Net decrease in cash, cash equivalents and restricted cash |
|
(22,042 |
) |
|
|
(20,063 |
) |
Cash, cash equivalents and restricted cash at beginning of year |
|
175,540 |
|
|
|
195,603 |
|
Cash, cash equivalents and restricted cash at end of year |
$ |
153,498 |
|
|
$ |
175,540 |
|
|
|||||||||||||||||||
Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures |
|||||||||||||||||||
(in thousands, except percentages and per share data) |
|||||||||||||||||||
(unaudited) |
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Three Months Ended |
|
Fiscal Year Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP gross profit |
$ |
41,290 |
|
|
$ |
35,177 |
|
|
$ |
41,437 |
|
|
$ |
161,004 |
|
|
$ |
171,918 |
|
Share-based compensation |
|
1,039 |
|
|
|
1,047 |
|
|
|
294 |
|
|
|
4,224 |
|
|
|
3,434 |
|
Amortization of purchased intangible |
|
811 |
|
|
|
812 |
|
|
|
812 |
|
|
|
3,247 |
|
|
|
3,247 |
|
Non-GAAP gross profit |
$ |
43,140 |
|
|
$ |
37,036 |
|
|
$ |
42,543 |
|
|
$ |
168,475 |
|
|
$ |
178,599 |
|
Non-GAAP gross margin as a % of revenue |
|
24.4 |
% |
|
|
22.5 |
% |
|
|
26.4 |
% |
|
|
24.2 |
% |
|
|
27.2 |
% |
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP operating expense |
$ |
52,908 |
|
|
$ |
45,835 |
|
|
$ |
42,936 |
|
|
$ |
189,440 |
|
|
$ |
175,674 |
|
Share-based compensation |
|
6,542 |
|
|
|
6,089 |
|
|
|
3,273 |
|
|
|
25,345 |
|
|
|
18,207 |
|
Settlement and legal costs related to government investigation |
|
4,461 |
|
|
|
54 |
|
|
|
352 |
|
|
|
4,977 |
|
|
|
524 |
|
Impairment of long-lived assets |
|
1,045 |
|
|
|
— |
|
|
|
— |
|
|
|
1,045 |
|
|
|
— |
|
Non-GAAP operating expense |
$ |
40,860 |
$ |
39,692 |
|
$ |
39,311 |
|
$ |
158,073 |
|
$ |
156,943 |
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP operating loss |
$ |
(11,618 |
) |
|
$ |
(10,658 |
) |
|
$ |
(1,499 |
) |
|
$ |
(28,436 |
) |
|
$ |
(3,756 |
) |
Share-based compensation |
|
7,581 |
|
|
|
7,136 |
|
|
|
3,567 |
|
|
|
29,569 |
|
|
|
21,641 |
|
Amortization of purchased intangible |
|
811 |
|
|
|
812 |
|
|
|
812 |
|
|
|
3,247 |
|
|
|
3,247 |
|
Settlement and legal costs related to government investigation |
|
4,461 |
|
|
|
54 |
|
|
|
352 |
|
|
|
4,977 |
|
|
|
524 |
|
Impairment of long-lived assets |
|
1,045 |
|
|
|
— |
|
|
|
— |
|
|
|
1,045 |
|
|
|
— |
|
Non-GAAP operating income (loss) |
$ |
2,280 |
|
|
$ |
(2,656 |
) |
|
$ |
3,232 |
|
|
$ |
10,402 |
|
|
$ |
21,656 |
|
Non-GAAP operating margin as a % of revenue |
|
1.3 |
% |
|
|
(1.6 |
)% |
|
|
2.0 |
% |
|
|
1.5 |
% |
|
|
3.3 |
% |
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP net loss |
$ |
(77,059 |
) |
|
$ |
(10,807 |
) |
|
$ |
(2,732 |
) |
|
$ |
(96,976 |
) |
|
$ |
(11,081 |
) |
Share-based compensation |
|
7,581 |
|
|
|
7,136 |
|
|
|
3,567 |
|
|
|
29,569 |
|
|
|
21,641 |
|
Amortization of purchased intangible |
|
811 |
|
|
|
812 |
|
|
|
812 |
|
|
|
3,247 |
|
|
|
3,247 |
|
Gain on change of equity interest in equity method investment |
|
— |
|
|
|
(505 |
) |
|
|
— |
|
|
|
(505 |
) |
|
|
— |
|
Equity method investment loss (gain) from equity investee |
|
(302 |
) |
|
|
260 |
|
|
|
704 |
|
|
|
1,526 |
|
|
|
4,789 |
|
Settlement and legal costs related to government investigation |
|
4,461 |
|
|
|
54 |
|
|
|
352 |
|
|
|
4,977 |
|
|
|
524 |
|
Impairment of equity method investment |
|
76,784 |
|
|
|
— |
|
|
|
— |
|
|
|
76,784 |
|
|
|
— |
|
Impairment of long-lived assets |
|
1,045 |
|
|
|
— |
|
|
|
— |
|
|
|
1,045 |
|
|
|
— |
|
Income tax effect of non-GAAP adjustments |
|
(12,584 |
) |
|
|
148 |
|
|
|
(78 |
) |
|
|
(12,670 |
) |
|
|
(627 |
) |
Non-GAAP net income (loss) |
$ |
737 |
|
|
$ |
(2,902 |
) |
|
$ |
2,625 |
|
|
$ |
6,997 |
|
|
$ |
18,493 |
|
Non-GAAP net margin as a % of revenue |
|
0.4 |
% |
|
|
(1.8 |
)% |
|
|
1.6 |
% |
|
|
1.0 |
% |
|
|
2.8 |
% |
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP net loss |
$ |
(77,059 |
) |
|
$ |
(10,807 |
) |
|
$ |
(2,732 |
) |
|
$ |
(96,976 |
) |
|
$ |
(11,081 |
) |
Share-based compensation |
|
7,581 |
|
|
|
7,136 |
|
|
|
3,567 |
|
|
|
29,569 |
|
|
|
21,641 |
|
Amortization and depreciation |
|
15,447 |
|
|
|
18,259 |
|
|
|
13,908 |
|
|
|
62,396 |
|
|
|
53,757 |
|
Equity method investment loss (gain) from equity investee |
|
(302 |
) |
|
|
260 |
|
|
|
704 |
|
|
|
1,526 |
|
|
|
4,789 |
|
Impairment of equity method investment |
|
76,784 |
|
|
|
— |
|
|
|
— |
|
|
|
76,784 |
|
|
|
||
Interest income |
|
(956 |
) |
|
|
(927 |
) |
|
|
(1,295 |
) |
|
|
(4,283 |
) |
|
|
(5,168 |
) |
Interest expense |
|
530 |
|
|
|
596 |
|
|
|
883 |
|
|
|
2,639 |
|
|
|
3,982 |
|
Income tax expense (benefit) |
|
(11,567 |
) |
|
|
660 |
|
|
|
1,006 |
|
|
|
(8,625 |
) |
|
|
3,649 |
|
EBITDAS |
$ |
10,458 |
|
|
$ |
15,177 |
|
|
$ |
16,041 |
|
|
$ |
63,030 |
|
|
$ |
71,569 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP diluted net loss per share |
$ |
(2.49 |
) |
|
$ |
(0.37 |
) |
|
$ |
(0.09 |
) |
|
$ |
(3.10 |
) |
|
$ |
(0.37 |
) |
Share-based compensation |
|
0.25 |
|
|
|
0.24 |
|
|
|
0.12 |
|
|
|
0.95 |
|
|
|
0.72 |
|
Amortization of purchased intangible |
|
0.03 |
|
|
|
0.03 |
|
|
|
0.03 |
|
|
|
0.10 |
|
|
|
0.11 |
|
Gain on change of equity interest in equity method investment |
|
— |
|
|
|
(0.02 |
) |
|
|
— |
|
|
|
(0.02 |
) |
|
|
— |
|
Equity method investment loss (gain) from equity investee |
|
(0.01 |
) |
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.05 |
|
|
|
0.16 |
|
Settlement and legal costs related to government investigation |
|
0.14 |
|
|
|
0.00 |
|
|
|
0.01 |
|
|
|
0.16 |
|
|
|
0.02 |
|
Impairment of equity method investment |
|
2.48 |
|
|
|
— |
|
|
|
— |
|
|
|
2.46 |
|
|
|
— |
|
Impairment of long-lived assets |
|
0.03 |
|
|
|
— |
|
|
|
— |
|
|
|
0.03 |
|
|
|
— |
|
Income tax effect of non-GAAP adjustments |
|
(0.41 |
) |
|
|
0.01 |
|
|
|
(0.00 |
) |
|
|
(0.41 |
) |
|
|
(0.02 |
) |
Non-GAAP diluted net income (loss) per share |
$ |
0.02 |
|
|
$ |
(0.10 |
) |
|
$ |
0.09 |
|
|
$ |
0.22 |
|
|
$ |
0.62 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Weighted average number of common shares used to compute GAAP diluted net income (loss) per share |
|
29,924 |
|
|
|
29,530 |
|
|
|
28,879 |
|
|
|
29,405 |
|
|
|
28,236 |
|
Weighted average number of common shares used to compute Non-GAAP diluted net income (loss) per share |
|
31,009 |
|
|
|
29,530 |
|
|
|
30,463 |
|
|
|
31,239 |
|
|
|
30,052 |
|
|
||||
Reconciliation of GAAP to Non-GAAP Outlook |
||||
For Fiscal Q1 Ending |
||||
(in millions, except percentages) |
||||
|
|
|
||
GAAP gross margin |
|
|
23.8 |
% |
Estimated impact of share-based compensation expense |
|
|
0.6 |
% |
Non-GAAP gross margin |
|
|
24.4 |
% |
|
|
|
||
GAAP operating expenses |
|
$ |
47.5 |
|
Estimated stock-based compensation expense |
|
|
(6.5 |
) |
Non-GAAP operating expenses |
|
$ |
41.0 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250804227446/en/
Investor and media inquiries:
In US +1 323 240 5796
In
gary@blueshirtgroup.co
steven@blueshirtgroup.co
+1 (360) 808-5154
Source: